These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15844093)

  • 1. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.
    Kontoyiannis DP; Hachem R; Lewis RE; Rivero GA; Torres HA; Thornby J; Champlin R; Kantarjian H; Bodey GP; Raad II
    Cancer; 2003 Jul; 98(2):292-9. PubMed ID: 12872348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S; Thibbadee C; Santanirand P
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
    Linden PK; Coley K; Fontes P; Fung JJ; Kusne S
    Clin Infect Dis; 2003 Jul; 37(1):17-25. PubMed ID: 12830404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
    Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
    Steinbach WJ; Stevens DA; Denning DW
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
    Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
    Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative antifungal therapy may improve survival in patients with Aspergillus brain abscess.
    Wasay M; Patel J; Azam I; Khan MA; Smego RA
    Clin Neurol Neurosurg; 2009 Sep; 111(7):565-7. PubMed ID: 19328623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
    Lionakis MS; Lewis RE; Chamilos G; Kontoyiannis DP
    Pharmacotherapy; 2005 Sep; 25(9):1174-80. PubMed ID: 16164392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?
    Mihu CN; Kassis C; Ramos ER; Jiang Y; Hachem RY; Raad II
    Cancer; 2010 Nov; 116(22):5290-6. PubMed ID: 20665889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ; Seaton S; Prentice HG; Kibbler CC
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.